273 related articles for article (PubMed ID: 26708031)
1. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
[TBL] [Abstract][Full Text] [Related]
2. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
3. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
[TBL] [Abstract][Full Text] [Related]
4. Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.
Peled S; Vangel M; Kikinis R; Tempany CM; Fennessy FM; Fedorov A
Acad Radiol; 2019 Sep; 26(9):e241-e251. PubMed ID: 30467073
[TBL] [Abstract][Full Text] [Related]
5. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
6. Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization.
Cristel G; Esposito A; Damascelli A; Briganti A; Ambrosi A; Brembilla G; Brunetti L; Antunes S; Freschi M; Montorsi F; Del Maschio A; De Cobelli F
Eur J Radiol; 2019 Sep; 118():51-57. PubMed ID: 31439258
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
[TBL] [Abstract][Full Text] [Related]
8. Variability induced by the MR imager in dynamic contrast-enhanced imaging of the prostate.
Brunelle S; Zemmour C; Bratan F; Mège-Lechevallier F; Ruffion A; Colombel M; Crouzet S; Sarran A; Rouvière O
Diagn Interv Imaging; 2018 Apr; 99(4):255-264. PubMed ID: 29428316
[TBL] [Abstract][Full Text] [Related]
9. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
[TBL] [Abstract][Full Text] [Related]
10. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
[TBL] [Abstract][Full Text] [Related]
11. Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection.
Ziayee F; Ullrich T; Blondin D; Irmer H; Arsov C; Antoch G; Quentin M; Schimmöller L
PLoS One; 2021; 16(4):e0249532. PubMed ID: 33819295
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic modeling of dynamic contrast-enhanced (DCE)-MRI in PI-RADS category 3 peripheral zone lesions: preliminary study evaluating DCE-MRI as an imaging biomarker for detection of clinically significant prostate cancers.
Abreu-Gomez J; Lim C; Cron GO; Krishna S; Sadoughi N; Schieda N
Abdom Radiol (NY); 2021 Sep; 46(9):4370-4380. PubMed ID: 33818626
[TBL] [Abstract][Full Text] [Related]
13. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer.
Ziayee F; Mueller-Lutz A; Gross J; Ullrich T; Quentin M; Arsov C; Antoch G; Wittsack HJ; Schimmöller L
Diagn Interv Radiol; 2022 Mar; 28(2):108-114. PubMed ID: 35548894
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of dynamic
Tau N; Berlin A; Yeung I; Halankar J; Murphy G; Jhaveri KS; Ghai S; Metser U
Br J Radiol; 2019 Feb; 92(1094):20180568. PubMed ID: 30383459
[TBL] [Abstract][Full Text] [Related]
15. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
16. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
Prabhu V; Rosenkrantz AB; Otazo R; Sodickson DK; Kang SK
J Magn Reson Imaging; 2019 May; 49(5):1400-1408. PubMed ID: 30629317
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.
Ream JM; Doshi AM; Dunst D; Parikh N; Kong MX; Babb JS; Taneja SS; Rosenkrantz AB
J Magn Reson Imaging; 2017 May; 45(5):1464-1475. PubMed ID: 27649481
[TBL] [Abstract][Full Text] [Related]
18. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
[TBL] [Abstract][Full Text] [Related]
19. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
[TBL] [Abstract][Full Text] [Related]
20. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.
Azahaf M; Haberlay M; Betrouni N; Ernst O; Behal H; Duhamel A; Ouzzane A; Puech P
J Magn Reson Imaging; 2016 Mar; 43(3):737-49. PubMed ID: 26303794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
